N/a
-Announces Publication of Data on Acthar® Gel (Repository Corticotropin Injection) from its Randomized, Double-Blind, Placebo-Controlled Phase 4 Study in Rheumatoid Arthritis (RA) in Rheumatology and Therapy
-Intraday pattern: Fade
-Levels: 3.3, 3.5, 3.7, 3.9
First test short of 3.6 to 3.75 level with VWAP and 15 minute level confluence
Plan was to scale until the 3.75 level but the stock pulled back before it got there so I took profits on the shares that I had, was the right call.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-04-15 10:49:23 | MNK | sell | $3.580 | short |
2020-04-15 10:50:24 | MNK | sell | $3.630 | short |
2020-04-15 10:56:30 | MNK | buy | $3.570 | short |
2020-04-15 10:56:30 | MNK | buy | $3.570 | short |
2020-04-15 10:56:30 | MNK | buy | $3.570 | short |
2020-04-15 10:56:30 | MNK | buy | $3.570 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!